Cerebras Systems priced its long-awaited initial public offering at $185.00 per share late on May 13, 2026 — meaningfully above the upsized $150–$160 range guided just one day earlier — selling 30,000,000 Class A shares for gross proceeds of about $5.55 billion. With the underwriters’ 30-day option to buy another 4.5 million shares, the total raise could top $6.38 billion, the company said in its pricing press release. The stock is set to begin trading on the Nasdaq Global Select Market on May 14 under the ticker CBRS, with the deal expected to close May 15.
The final price lands roughly 54% above the midpoint of Cerebras’ original $115–$125 range and 19% above the upsized $150–$160 range that ran on Wall Street’s IPO calendar yesterday — a sequence that compresses an entire roadshow’s worth of upward revisions into a few short weeks of demand discovery.
Deal terms
| Item | Detail |
|---|---|
| Issuer | Cerebras Systems, Inc. |
| Ticker / Exchange | CBRS / Nasdaq Global Select |
| Offering price | $185.00 / share |
| Shares offered (base) | 30,000,000 Class A |
| Base proceeds | $5.55 billion |
| Greenshoe option | 4,500,000 shares (30 days) |
| Max total proceeds | ~$6.38 billion |
| First trading day | May 14, 2026 |
| Expected closing | May 15, 2026 |
| Lead bookrunners | Morgan Stanley, Citigroup, Barclays, UBS |
| Other bookrunners | Mizuho, TD Cowen |
From $115 to $185: a price ratchet in four steps
Cerebras filed its updated S-1 with an initial price range of $115–$125 a share and was expected to raise about $3.5 billion. Demand from institutional accounts pushed the bookrunners to revise the range twice — first to $125–$135, then to $150–$160 — before settling on a print above all of them.
That kind of ratchet is rare. Most U.S. tech IPOs price within the marketed range; pricing 19% above an already-upsized range signals an order book where most allocations were heavily oversubscribed. Bankers typically push price upward when total demand exceeds 10–20× the deal at the marketed range — at which point the question stops being “will it price?” and becomes “how much money are we leaving for first-day buyers?”
The arc of Cerebras’ bookbuilding also illustrates a structural feature of the U.S. IPO process that gets overlooked: the marketed range is not a guidepost the market negotiates around — it is a soft anchor that the lead manager can move repeatedly so long as the syndicate refiles updated free-writing prospectuses and the demand sticks. The SEC’s investor education materials describe the process; in practice the bookbuild is dynamic right up to the pricing call.
Why investors stretched
Cerebras is one of the few merchant-silicon names positioned as a credible alternative to NVIDIA for training and inference. Its Wafer-Scale Engine bundles roughly 900,000 AI-optimized cores onto a single die — a radically different design from stitching together discrete GPUs across a rack. The company posted revenue of approximately $510 million in FY2025, up from $24.6 million in FY2022, an unusually steep growth curve for a pre-IPO chip vendor (per disclosures summarized in the company’s IPO materials and pre-IPO reporting).
Demand is anchored by two customers: OpenAI and Abu Dhabi’s MBZUAI together accounted for roughly 86% of FY2025 revenue, with OpenAI extending a $1 billion loan and committing to multi-year compute purchases worth more than $10 billion through 2030. That concentration is also Cerebras’ biggest disclosed risk factor.
The deal cleared its final geopolitical hurdle in March 2025, when the Committee on Foreign Investment in the United States (CFIUS) approved the restructured G42 (Abu Dhabi) ownership stake that had previously frozen the IPO.
What the print means for the IPO market
Cerebras joins a thickening pipeline of AI-infrastructure offerings — including Blackstone’s Digital Infrastructure REIT (BXDC) and Fervo Energy (FRVO), both pricing this week — that point to renewed risk appetite at the high-multiple end of the market. At a base raise of $5.55 billion, Cerebras alone accounts for more new equity issuance than the rest of this week’s Nasdaq IPO calendar combined, per the Nasdaq IPO listings.
Whether the bid holds beyond the first trading day is a separate question. The Class A insider lock-up is scheduled to expire on November 10, 2026 — roughly 180 days post-IPO — which is when the float will materially expand and any concentrated early shareholders are first free to sell.
Use of proceeds, according to the company, is split between research and development on next-generation wafer-scale silicon, expansion of inference capacity for cloud customers, and general corporate purposes. Cerebras has not announced a specific acquisition or large capex commitment tied to the raise, which means most of the $5.55 billion will sit on the balance sheet as net cash — itself a competitive advantage in a market where capital expenditure is the binding constraint on data-center scale-out.
The other watch-item is concentration. With OpenAI and MBZUAI together representing roughly 86% of FY2025 revenue, the IPO is in effect a derivative bet on two specific customer relationships continuing to scale. Diversifying away from that concentration — onto cloud partners like AWS and Meta-affiliated workloads referenced on the company’s site — is the single most important operational milestone analysts will track over the next four quarters.
Sources
- Cerebras Systems — Pricing of Initial Public Offering (May 13, 2026)
- Cerebras Systems — company website & IPO materials
- Nasdaq — IPO Calendar
- U.S. Department of the Treasury — CFIUS
Disclosure: This article was produced with AI assistance and reviewed before publication. It is for informational purposes only and is not investment advice.